Limited coverage drugs – sarilumab

Last updated on February 6, 2024

Generic name



150 mg/1.14 mL

200 mg/ 1.14 mL


pre-filled syringe or pre-filled pen for subcutaneous injection

Special Authority criteria

Approval period

For the treatment of rheumatoid arthritis (RA) when:

  • Prescribed by a rheumatologist


  • Prescribed according to established criteria (as indicated on the applicable Special Authority form below)

First approval: 1 year

Renewal: 1 year



Practitioner exemptions

  • None

Special notes

  • PharmaCare covers a maximum 28-day supply of sarilumab per fill. Coverage is limited to 200 mg or 150 mg every 2 weeks

Special Authority requests